133 related articles for article (PubMed ID: 17178890)
1. A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells.
Zerbini LF; Czibere A; Wang Y; Correa RG; Otu H; Joseph M; Takayasu Y; Silver M; Gu X; Ruchusatsawat K; Li L; Sarkar D; Zhou JR; Fisher PB; Libermann TA
Cancer Res; 2006 Dec; 66(24):11922-31. PubMed ID: 17178890
[TBL] [Abstract][Full Text] [Related]
2. Suppression of growth arrest and DNA damage-inducible 45alpha expression confers resistance to sulindac and indomethacin-induced gastric mucosal injury.
Chiou SK; Hodges A; Hoa N
J Pharmacol Exp Ther; 2010 Sep; 334(3):693-702. PubMed ID: 20498252
[TBL] [Abstract][Full Text] [Related]
3. Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene.
Saito Y; Miyahara R; Gopalan B; Litvak A; Inoue S; Shanker M; Branch CD; Mhashilkar AM; Roth JA; Chada S; Ramesh R
Cancer Gene Ther; 2005 Mar; 12(3):238-47. PubMed ID: 15578066
[TBL] [Abstract][Full Text] [Related]
4. mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.
Chada S; Bocangel D; Ramesh R; Grimm EA; Mumm JB; Mhashilkar AM; Zheng M
Mol Ther; 2005 May; 11(5):724-33. PubMed ID: 15851011
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
6. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells.
Chen YL; Lin PC; Chen SP; Lin CC; Tsai NM; Cheng YL; Chang WL; Lin SZ; Harn HJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):746-56. PubMed ID: 17715378
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells.
Aleman MJ; DeYoung MP; Tress M; Keating P; Perry GW; Narayanan R
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12765-70. PubMed ID: 16129820
[TBL] [Abstract][Full Text] [Related]
8. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
Shain SA
Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
[TBL] [Abstract][Full Text] [Related]
9. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
10. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K
Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066
[TBL] [Abstract][Full Text] [Related]
11. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
12. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
Verheul HM; Qian DZ; Carducci MA; Pili R
Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
[TBL] [Abstract][Full Text] [Related]
13. Gadd45gamma is androgen-responsive and growth-inhibitory in prostate cancer cells.
Jiang F; Wang Z
Mol Cell Endocrinol; 2004 Jan; 213(2):121-9. PubMed ID: 15062559
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
Andrews P; Zhao X; Allen J; Li F; Chang M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.
Zerbini LF; Tamura RE; Correa RG; Czibere A; Cordeiro J; Bhasin M; Simabuco FM; Wang Y; Gu X; Li L; Sarkar D; Zhou JR; Fisher PB; Libermann TA
PLoS One; 2011; 6(9):e24285. PubMed ID: 21931671
[TBL] [Abstract][Full Text] [Related]
16. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
17. mda-7/IL-24 inhibits the proliferation of hematopoietic malignancies in vitro and in vivo.
Dong CY; Zhang F; Duan YJ; Yang BX; Lin YM; Ma XT
Exp Hematol; 2008 Aug; 36(8):938-46. PubMed ID: 18468766
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
[TBL] [Abstract][Full Text] [Related]
19. mda-7 (IL-24): signaling and functional roles.
Sarkar D; Su ZZ; Lebedeva IV; Sauane M; Gopalkrishnan RV; Dent P; Fisher PB
Biotechniques; 2002 Oct; Suppl():30-9. PubMed ID: 12395925
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.
Dial EJ; Doyen JR; Lichtenberger LM
Cancer Chemother Pharmacol; 2006 Feb; 57(3):295-300. PubMed ID: 16032431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
